Cofactor partners with clients to drive the full potential of their innovative medicines through a high impact, collaborative approach.
Establishing new standards of care through strategy, operational planning and management
Data analysis, market research and complex modeling to inform strategic decisions
Insight and analytical support for in-licensing, out-licensing and acquisition opportunities
helping clients assess opportunities, nurture pipelines and launch blockbusters
including Oncology, Orphan, Diagnostics, Biologics, Vaccines and General Medicine
to align resources with issues for facing emerging and established customers alike
Cofactor partnered with a biotechnology organization to inform critical investment decisions about a potential treatment for SARS-CoV-2 infection.
Co-commercialization or co-promotion agreements have become the new norm in the life sciences industry, and all have one thing in common - they are challenging. Cofactor provides specific alliance expertise, capabilities, and tools that can help your alliance work more effectively.